STOCK TITAN

LivaNova to Present at the Stifel 2020 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

LivaNova PLC (NASDAQ:LIVN) announced that CEO Damien McDonald will present at the Stifel 2020 Virtual Healthcare Conference on November 17 at 10:40 a.m. ET. The live discussion will be accessible via a webcast on the company's Investors section of their website. A replay will be available for 90 days following the event. LivaNova, headquartered in London, focuses on innovative medical technologies across two business sectors: Cardiovascular and Neuromodulation, serving over 100 countries worldwide.

Positive
  • None.
Negative
  • None.

LONDON--()--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17 at 10:40 a.m. Eastern Time.

The discussion will be available to all interested parties through a live webcast accessible via the Investors section of the LivaNova website at www.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. Replays of the webcast will be available on the LivaNova website within 24 hours after the live presentation for 90 days after the event.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. LivaNova operates as two businesses: Cardiovascular and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston (U.S.), respectively.

For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains “forward-looking statements” concerning our goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual results may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented by any risk factors contained in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. We undertake no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

Contacts

LivaNova PLC Investor Relations and Media Contacts

Melissa Farina, +1 (281) 228-7262
VP, Investor Relations
InvestorRelations@livanova.com

Deanna Wilke, +1 (281) 727-2764
VP, Corporate Communications
Corporate.Communications@livanova.com

FAQ

What is the date of LivaNova's presentation at the Stifel 2020 Virtual Healthcare Conference?

LivaNova's presentation is scheduled for November 17 at 10:40 a.m. Eastern Time.

How can I watch LivaNova's presentation at the Stifel 2020 Virtual Healthcare Conference?

You can watch LivaNova's presentation through a live webcast accessible on the Investors section of their official website.

Where is LivaNova PLC headquartered?

LivaNova PLC is headquartered in London.

What are the two main business sectors of LivaNova PLC?

LivaNova operates in two main sectors: Cardiovascular and Neuromodulation.

How long will the replay of LivaNova's conference presentation be available?

The replay of LivaNova's conference presentation will be available for 90 days after the event.

LivaNova PLC Ordinary Shares

NASDAQ:LIVN

LIVN Rankings

LIVN Latest News

LIVN Stock Data

2.90B
53.69M
0.33%
101.09%
3.64%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LONDON